Getting to an ImprOved Understanding of Low-Density Lipoprotein-Cholesterol and Dyslipidemia Management (GOULD): Methods and baseline data of a registry of high cardiovascular risk patients in the United States-Reference-Cited by-同舟云学术

Getting to an ImprOved Understanding of Low-Density Lipoprotein-Cholesterol and Dyslipidemia Management (GOULD): Methods and baseline data of a registry of high cardiovascular risk patients in the United States

Published:2020-01 Issue: Volume:219 Page:70-77
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Cannon Christopher P.,de Lemos James A.,Rosenson Robert S.,Ballantyne Christie M.,Liu Yuyin,Yazdi Daniel,Elliott-Davey Mary,Mues Katherine E.,Bhatt Deepak L.,Kosiborod Mikhail N.

Funder

Amgen

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference35 articles.

1. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials;Baigent;Lancet,2010

2. Ezetimibe added to statin therapy after acute coronary syndromes;Cannon;N Engl J Med,2015

3. Evolocumab and clinical outcomes in patients with cardiovascular disease;Sabatine;N Engl J Med,2017

4. Alirocumab and cardiovascular outcomes after acute coronary syndrome;Schwartz;N Engl J Med,2018

5. Intensive versus moderate lipid lowering with statins after acute coronary syndromes;Cannon;N Engl J Med,2004

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of Residual Risk and Recurrent Event Trends Following Acute Coronary Syndrome: A Cohort Study;2024-09-10

2. LOGAN-CV: A Prospective Study of a Multifaceted Intervention Targeting United States Clinicians to Improve Guideline-Based Management of Lipid-Lowering Therapy;Advances in Therapy;2023-11-21

3. Practical solutions for implementation of blood cholesterol guidelines in clinical practice;Trends in Cardiovascular Medicine;2023-08

4. Use of optimal medical therapy in patients with diabetes and atherosclerotic cardiovascular disease: Insights from a prospective longitudinal cohort study;Diabetes, Obesity and Metabolism;2023-03-07

5. LDL-C target attainment in secondary prevention of ASCVD in the United States: barriers, consequences of nonachievement, and strategies to reach goals;Postgraduate Medicine;2022-10-06